Average Co-Inventor Count = 4.44
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ardea Biosciences, Inc (21 from 63 patents)
2. Schering Corporation (4 from 1,829 patents)
3. Valeant Research and Development (4 from 7 patents)
4. Ribapharm Inc. (4 from 5 patents)
5. Valeant Pharmaceuticals North America (2 from 7 patents)
6. Other (1 from 832,680 patents)
7. Bayer Schering Pharma Ag (1 from 192 patents)
8. Valeant Pharmaceuticals International (1 from 22 patents)
9. Ardes Biosciences Inc. (1 from 1 patent)
39 patents:
1. 8946273 - S-Triazolyl alpha-mercapto acetanilides as inhibitors of HIV reverse transcriptase
2. 8829052 - Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
3. 8722929 - N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
4. 8716318 - Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors
5. 8552043 - [object Object]
6. 8481581 - S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase
7. 8354532 - Pyrrolo [2,3-D] pyrimidines as non-nucleoside reverse transcriptase inhibitors for treatment of HIV
8. 8324223 - Substituted thieno [2,3-d] pyrimidines as HIV inhibitors
9. 8252828 - S-triazolyl α-mercapto acetanilides as inhibitors of HIV reverse transcriptase
10. 8227601 - Diaryl-purines, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitor for treatment of HIV
11. 8211898 - Substituted thieno[3,2-d]pyrimidines as HIV inhibitors
12. 8106205 - [object Object]
13. 8101799 - Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
14. 8063049 - Inhibitors of MEK
15. 7947721 - S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase